清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

间质细胞 封锁 癌症研究 细胞毒性T细胞 CD8型 医学 肿瘤微环境 转化生长因子 癌细胞 抗体 癌症 免疫学 免疫系统 生物 受体 内科学 体外 生物化学
作者
Sanjeev Mariathasan,Shannon J. Turley,Dorothee Nickles,Alessandra Castiglioni,Kobe Chi Yung Yuen,Yulei Wang,Edward Ernest Kadel,Hartmut Koeppen,Jillian L. Astarita,Rafael A. Cubas,Suchit Jhunjhunwala,Romain Banchereau,Yagai Yang,Yinghui Guan,Cecile M. Chalouni,James M. Ziai,Yasin Şenbabaoğlu,Stephen P. Santoro,Daniel M. Sheinson,Jeffrey Hung
出处
期刊:Nature [Nature Portfolio]
卷期号:554 (7693): 544-548 被引量:5359
标识
DOI:10.1038/nature25501
摘要

In humans, TGFβ signalling is associated with lack of response to immunotherapy in immune-excluded tumours; in mouse models of this immune phenotype, robust tumour infiltration by T cells and tumour regression are observed only when checkpoint inhibition is combined with inhibition of TGFβ signalling. Immune checkpoint blockade is showing clinical promise in the treatment of several cancer types, but the determinants of response need to be better established. Sanjeev Mariathasan and colleagues show that specific immune cell phenotypes and a high neoantigen burden are predictors of good responses to therapy with atezolizumab, an anti-PD-L1 agent, in patients with metastatic urothelial carcinoma. Lack of response to therapy is associated with increased TGFβ signalling in fibroblasts in the tumour microenvironment. Combining TGFβ blockade with immune checkpoint blockade in mouse models increases the anti-tumour efficacy of the therapy, suggesting that identifying and targeting microenvironmental regulators of anti-tumour immunity may increase the reach of immunotherapy approaches. Therapeutic antibodies that block the programmed death-1 (PD-1)–programmed death-ligand 1 (PD-L1) pathway can induce robust and durable responses in patients with various cancers, including metastatic urothelial cancer1,2,3,4,5. However, these responses only occur in a subset of patients. Elucidating the determinants of response and resistance is key to improving outcomes and developing new treatment strategies. Here we examined tumours from a large cohort of patients with metastatic urothelial cancer who were treated with an anti-PD-L1 agent (atezolizumab) and identified major determinants of clinical outcome. Response to treatment was associated with CD8+ T-effector cell phenotype and, to an even greater extent, high neoantigen or tumour mutation burden. Lack of response was associated with a signature of transforming growth factor β (TGFβ) signalling in fibroblasts. This occurred particularly in patients with tumours, which showed exclusion of CD8+ T cells from the tumour parenchyma that were instead found in the fibroblast- and collagen-rich peritumoural stroma; a common phenotype among patients with metastatic urothelial cancer. Using a mouse model that recapitulates this immune-excluded phenotype, we found that therapeutic co-administration of TGFβ-blocking and anti-PD-L1 antibodies reduced TGFβ signalling in stromal cells, facilitated T-cell penetration into the centre of tumours, and provoked vigorous anti-tumour immunity and tumour regression. Integration of these three independent biological features provides the best basis for understanding patient outcome in this setting and suggests that TGFβ shapes the tumour microenvironment to restrain anti-tumour immunity by restricting T-cell infiltration.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
虚幻的雁山完成签到,获得积分10
3秒前
沉默的樱完成签到,获得积分10
11秒前
紫熊发布了新的文献求助10
17秒前
19秒前
23秒前
整齐念薇完成签到,获得积分10
30秒前
41秒前
英姑的应助被傻傻的芷巧采纳,获得10
47秒前
50秒前
超级冷梅完成签到,获得积分10
53秒前
chen发布了新的文献求助10
54秒前
CMC智能助手完成签到,获得积分10
54秒前
无私鹤轩完成签到,获得积分10
1分钟前
凶狠的草莓完成签到,获得积分10
1分钟前
1分钟前
故意的听安完成签到,获得积分10
1分钟前
1分钟前
紫熊发布了新的文献求助10
1分钟前
6666发布了新的文献求助10
1分钟前
1分钟前
超级诗桃完成签到,获得积分10
1分钟前
chen完成签到,获得积分10
1分钟前
1分钟前
姜OMG发布了新的文献求助10
1分钟前
如歌完成签到,获得积分10
1分钟前
科研通AI2S的应助被6666采纳,获得10
1分钟前
紫熊发布了新的文献求助10
1分钟前
自然如曼完成签到 ,获得积分10
1分钟前
2分钟前
小巧惜蕊完成签到,获得积分10
2分钟前
故意的绿真完成签到,获得积分10
2分钟前
拼搏的小凝完成签到,获得积分10
2分钟前
2分钟前
紫熊发布了新的文献求助10
2分钟前
仁爱的鹤轩完成签到,获得积分10
2分钟前
2分钟前
3分钟前
紫熊发布了新的文献求助10
3分钟前
英勇问晴完成签到,获得积分10
3分钟前
自然的妙梦完成签到,获得积分10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173194
求助须知:如何正确求助?哪些是违规求助? 9565558
关于积分的说明 21780496
捐赠科研通 7767299
什么是DOI,文献DOI怎么找? 3431542
关于科研通互助平台的介绍 2555697
邀请新用户注册赠送积分活动 2476688